Help us: Donate
Follow us on:
×

The Rejuveron Age Better, Live Longer Symposium – May 10th

This symposium will feature three hours of talks.

RejuveronRejuveron
 

The Rejuveron Age Better, Live Longer Symposium is only a few days away now! On May 10th, 2022 at 5:00 – 8:00 PM Central European Time, this one-day virtual event will explore the world of aging research and longevity.

The event will consist of a series of three discussion panels, and you can join the event free of charge to hear from leading economists, entrepreneurs, and investors about the future of therapies to promote healthy aging.

João Pedro de Magalhães, Vadim Gladyshev, and Matt Kaeberlein are names that are sure to be familiar with our regular readers. They are important figures in the aging research community and will be part of the research discussion panel.

Science journalist and broadcaster, Vivienne Parry OBE, will be the host of the three interactive panel sessions that make up the event, and there will be opportunities to ask questions during the live event.

Lifespan.io President Keith Comito will be one of the speakers at the event and is appearing in the investment panel. He was recently interviewed by Rejuveron and shared his thoughts on aging and the goal to increase healthy human lifespans.

What sparked your interest to get into aging research?

I would like to think that no matter life’s circumstances I would have come to recognize the importance of this field, but I can’t deny that certain experiences in my youth are related. Namely experiencing the passing of multiple loved ones as a child, and later caring for my grandmother until her death from Alzheimer’s disease. The former gave me an early preoccupation with life’s fragility, and the latter solidified my resolve to overcome it.

You can find out more and why Keith believes that “Aging intersects with absolutely every other aspect of human experience” by visiting the Rejuveron website.

We highly recommend registering for this free event, but hurry, there are only a few days left!

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Longevity Investors Lunch at Davos

A Longevity Investors Lunch hosted by Maximon, Longevity Investors Conference, and Biolytica has been hosted at a satellite event of...

Open Longevity Foundation Announces Open Genes Database

Open Longevity Foundation has announced Open Genes, a database of longevity-associated genes and a tool for future anti-aging therapy development....

Gero Enters Research Collaboration with Pfizer

Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform...

Immunis Begins Clinical Trial of Stem Cell Secretome

Intending to treat sarcopenia, the private biotechnology company Immunis has begun a human clinical trial of a stem cell secretome...

No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.